drugset / Trial / NCT00359229

Stilnox Treatment in Elderly Patients With Insomnia

NCT00359229

Phase 4 Completed 115 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Primary objective: 1\. To evaluate the efficacy of Zolpidem 5mg for 1 week in elderly patients with insomnia in China Secondary objectives: 1. To evaluate the safety of Zolpidem 5mg for 3 weeks in elderly patients with insomnia in China. 2. To evaluate the efficacy of Zolpidem 5mg for 3 weeks in elderly patients with insomnia in China

Timeline

Start
2006-07
Primary completion
2007-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 5 mg

Indications